> top > projects > semrep-sample > docs > PubMed:10101034 > annotations

PubMed:10101034 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T1 0-10 INHIBITS denotes Inhibition
E1-ti-1 14-30 cui:C0387583 denotes cyclooxygenase-2
E2-ti-1 31-41 cui:C0185117 denotes expression
E3-ti-1 63-74 cui:C0243072 denotes derivatives
E4-ti-1 78-88 cui:C0036075 denotes salicylate
E5-ti-1 90-99 cui:C0077126 denotes triflusal
E6-ti-1 122-132 cui:C0870883 denotes metabolite
E7-ti-1 134-173 cui:C0048733 denotes 2-hydroxy-4-trifluoromethylbenzoic acid
E1-ab-1 179-190 cui:C0302350 denotes therapeutic
E2-ab-1 191-200 cui:C0237399 denotes potential
E3-ab-1 204-209 cui:C0013227 denotes drugs
E4-ab-1 225-234 cui:C0857127 denotes induction
E5-ab-1 238-254 cui:C0387583 denotes cyclooxygenase-2
E1-ab-2 281-284 cui:C0205448 denotes two
E2-ab-2 303-313 cui:C0036075 denotes salicylate
E3-ab-2 314-325 cui:C0243072 denotes derivatives
E4-ab-2 355-367 cui:C0053225 denotes benzoic acid
T3 355-378 ISA denotes benzoic acid (triflusal
T4 355-378 ISA denotes benzoic acid (triflusal
T5 355-378 ISA denotes benzoic acid (triflusal
T9 355-378 compared_with denotes benzoic acid (triflusal
E5-ab-2 369-378 cui:C0077126 denotes triflusal
E6-ab-2 401-411 cui:C0870883 denotes metabolite
E7-ab-2 414-451 cui:C0020317 denotes hydroxy-4-trifluoromethylbenzoic acid
T2 464-472 compared_with denotes compared
E8-ab-2 478-485 cui:C0004057 denotes aspirin
E9-ab-2 490-507 cui:C0037549 denotes sodium salicylate
E10-ab-2 511-546 cui:C1257954 denotes cyclooxygenase-2 (COX-2) inhibitors
T6 565-567 LOCATION_OF denotes in
E11-ab-2 568-577 cui:C0521009 denotes bacterial
E12-ab-2 578-596 cui:C0023810 denotes lipopolysaccharide
E13-ab-2 597-606 cui:C1515877 denotes activated
E14-ab-2 607-612 cui:C0020114 denotes human
E15-ab-2 613-618 cui:C0005767 denotes blood
E16-ab-2 620-629 cui:C0077126 denotes triflusal
E17-ab-2 631-638 cui:C0004057 denotes aspirin
E18-ab-2 644-647 cui:C0020317 denotes HTB
E19-ab-2 653-656 cui:C1518422 denotes not
E20-ab-2 657-674 cui:C0037549 denotes sodium salicylate
T7 676-685 DISRUPTS denotes inhibited
T8 676-685 DISRUPTS denotes inhibited
E21-ab-2 686-691 cui:C0387583 denotes COX-2
E22-ab-2 692-700 cui:C0086597 denotes mediated
E23-ab-2 701-735 cui:C1514503 denotes prostaglandin E2 (PGE2) production
E24-ab-2 737-741 cui:C0600495 denotes IC50
E1-ab-3 803-812 cui:C0077126 denotes triflusal
E2-ab-3 817-824 cui:C0004057 denotes aspirin
T10 825-834 INHIBITS denotes inhibited
T11 825-834 INHIBITS denotes inhibited
E3-ab-3 844-849 cui:C0387583 denotes COX-2
E4-ab-3 850-856 cui:C0014442 denotes enzyme
E1-ab-4 871-879 cui:C0750489 denotes apparent
E2-ab-4 880-891 cui:C1290905 denotes discrepancy
E3-ab-4 910-913 cui:C0020317 denotes HTB
E4-ab-4 918-927 cui:C0077126 denotes triflusal
E5-ab-4 941-948 cui:C0004057 denotes aspirin
E6-ab-4 953-963 cui:C0036075 denotes salicylate
E7-ab-4 1014-1019 cui:C0387583 denotes COX-2
E8-ab-4 1020-1038 cui:C1171362 denotes protein expression
T13 1039-1041 LOCATION_OF denotes in
E9-ab-4 1042-1052 cui:C0205100 denotes peripheral
E10-ab-4 1053-1058 cui:C0020114 denotes human
T12 1053-1076 PART_OF denotes human mononuclear cells
E11-ab-4 1059-1076 cui:C0806987 denotes mononuclear cells
E1-ab-5 1099-1106 cui:C1517331 denotes further
E2-ab-5 1122-1125 cui:C0034693 denotes rat
E3-ab-5 1126-1129 cui:C0001861 denotes air
E4-ab-5 1136-1141 cui:C0026336 denotes model
E5-ab-5 1165-1172 cui:C0004057 denotes aspirin
E6-ab-5 1177-1186 cui:C0077126 denotes triflusal
T14 1187-1196 DISRUPTS denotes inhibited
T15 1187-1196 DISRUPTS denotes inhibited
E7-ab-5 1197-1212 cui:C1514503 denotes PGE2 production
E8-ab-5 1270-1279 cui:C0077126 denotes triflusal
E9-ab-5 1280-1287 cui:C1522326 denotes treated
E10-ab-5 1288-1295 cui:C0003062 denotes animals
E11-ab-5 1305-1313 cui:C0547047 denotes decrease
E12-ab-5 1317-1322 cui:C0387583 denotes COX-2
E13-ab-5 1323-1333 cui:C0185117 denotes expression
E1-ab-6 1340-1349 cui:C1547020 denotes different
E2-ab-6 1350-1358 cui:C0004927 denotes behavior
E3-ab-6 1379-1383 cui:C0449719 denotes part
E4-ab-6 1396-1403 cui:C0085732 denotes ability
E5-ab-6 1407-1410 cui:C0020317 denotes HTB
E6-ab-6 1415-1424 cui:C0077126 denotes triflusal
E7-ab-6 1456-1476 cui:C0040648 denotes transcription factor
E8-ab-6 1477-1484 cui:C0521447 denotes nuclear
E9-ab-6 1504-1510 cui:C0205250 denotes higher
E10-ab-6 1511-1517 cui:C0439792 denotes extent
E11-ab-6 1523-1530 cui:C0004057 denotes aspirin
E12-ab-6 1535-1552 cui:C0037549 denotes sodium salicylate
E1-ab-7 1563-1571 cui:C0442796 denotes addition
E2-ab-7 1575-1585 cui:C0311403 denotes inhibiting
E3-ab-7 1590-1595 cui:C0387583 denotes COX-2
E4-ab-7 1596-1604 cui:C0439167 denotes activity
E5-ab-7 1608-1619 cui:C0302350 denotes therapeutic
E6-ab-7 1620-1634 cui:C0086045 denotes concentrations
E7-ab-7 1636-1645 cui:C0077126 denotes triflusal
T16 1636-1689 ISA denotes triflusal is able to block through its metabolite HTB
T18 1636-1689 INHIBITS denotes triflusal is able to block through its metabolite HTB
E8-ab-7 1649-1653 cui:C1299581 denotes able
T17 1657-1662 INHIBITS denotes block
E9-ab-7 1675-1685 cui:C0870883 denotes metabolite
E10-ab-7 1686-1689 cui:C0020317 denotes HTB
E11-ab-7 1694-1704 cui:C0185117 denotes expression
E12-ab-7 1708-1711 cui:C0205314 denotes new
E13-ab-7 1712-1718 cui:C0014442 denotes enzyme
E14-ab-7 1748-1752 cui:C0012472 denotes PGE2
E15-ab-7 1753-1762 cui:C0869032 denotes synthesis
E1-ab-8 1764-1773 cui:C0077126 denotes Triflusal
E2-ab-8 1778-1781 cui:C0020317 denotes HTB
E3-ab-8 1803-1810 cui:C1280500 denotes effects
E4-ab-8 1814-1823 cui:C1522240 denotes processes
T19 1824-1826 COEXISTS_WITH denotes in
T20 1824-1826 COEXISTS_WITH denotes in
E5-ab-8 1833-1840 cui:C1515568 denotes de novo
E6-ab-8 1841-1846 cui:C0387583 denotes COX-2
E7-ab-8 1847-1857 cui:C0185117 denotes expression
E8-ab-8 1880-1887 cui:C0332464 denotes broader
E9-ab-8 1898-1910 cui:C1521733 denotes pathological
E10-ab-8 1931-1936 cui:C0017337 denotes genes
E11-ab-8 1943-1950 cui:C0521447 denotes nuclear
E12-ab-8 1951-1957 cui:C1521761 denotes factor
E13-ab-8 1965-1972 cui:C0243148 denotes control
R1 E4-ti-1 T1 subjectOf salicylate,Inhibition
R10 E7-ab-2 T5 objectOf hydroxy-4-trifluoromethylbenzoic acid,benzoic acid (triflusal
R11 E15-ab-2 T6 subjectOf blood,in
R12 E10-ab-2 T6 objectOf cyclooxygenase-2 (COX-2) inhibitors,in
R13 E20-ab-2 T7 subjectOf sodium salicylate,inhibited
R14 E23-ab-2 T7 objectOf prostaglandin E2 (PGE2) production,inhibited
R15 E9-ab-2 T8 subjectOf sodium salicylate,inhibited
R16 E23-ab-2 T8 objectOf prostaglandin E2 (PGE2) production,inhibited
R17 E5-ab-2 T9 subjectOf triflusal,benzoic acid (triflusal
R18 E8-ab-2 T9 objectOf aspirin,benzoic acid (triflusal
R19 E2-ab-3 T10 subjectOf aspirin,inhibited
R2 E1-ti-1 T1 objectOf cyclooxygenase-2,Inhibition
R20 E3-ab-3 T10 objectOf COX-2,inhibited
R21 E1-ab-3 T11 subjectOf triflusal,inhibited
R22 E3-ab-3 T11 objectOf COX-2,inhibited
R23 E11-ab-4 T12 subjectOf mononuclear cells,human mononuclear cells
R24 E10-ab-4 T12 objectOf human,human mononuclear cells
R25 E11-ab-4 T13 subjectOf mononuclear cells,in
R26 E7-ab-4 T13 objectOf COX-2,in
R27 E6-ab-5 T14 subjectOf triflusal,inhibited
R28 E7-ab-5 T14 objectOf PGE2 production,inhibited
R29 E5-ab-5 T15 subjectOf aspirin,inhibited
R3 E7-ab-2 T2 subjectOf hydroxy-4-trifluoromethylbenzoic acid,compared
R30 E7-ab-5 T15 objectOf PGE2 production,inhibited
R31 E7-ab-7 T16 subjectOf triflusal,triflusal is able to block through its metabolite HTB
R32 E10-ab-7 T16 objectOf HTB,triflusal is able to block through its metabolite HTB
R33 E7-ab-7 T17 subjectOf triflusal,block
R34 E10-ab-7 T17 objectOf HTB,block
R35 E7-ab-7 T18 subjectOf triflusal,triflusal is able to block through its metabolite HTB
R36 E7-ab-7 T18 objectOf triflusal,triflusal is able to block through its metabolite HTB
R37 E2-ab-8 T19 subjectOf HTB,in
R38 E6-ab-8 T19 objectOf COX-2,in
R39 E1-ab-8 T20 subjectOf Triflusal,in
R4 E8-ab-2 T2 objectOf aspirin,compared
R40 E6-ab-8 T20 objectOf COX-2,in
R5 E5-ab-2 T3 subjectOf triflusal,benzoic acid (triflusal
R6 E4-ab-2 T3 objectOf benzoic acid,benzoic acid (triflusal
R7 E5-ab-2 T4 subjectOf triflusal,benzoic acid (triflusal
R8 E18-ab-2 T4 objectOf HTB,benzoic acid (triflusal
R9 E5-ab-2 T5 subjectOf triflusal,benzoic acid (triflusal